Peachtree Investment Partners, LLC Bristol Myers Squibb CO Transaction History

Peachtree Investment Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $38,670 - $43,239	-668 Reduced 9.7%	6,218 $360,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $62,308 - $69,183	-978 Reduced 12.44%	6,886 $440,000
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $49,348 - $55,972	-751 Reduced 8.72%	7,864 $545,000
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $155,723 - $184,398	-2,274 Reduced 20.88%	8,615 $619,000
Q3 2022 Nov 08, 2022	SELL	$0.13 - $76.84 $1,204 - $712,229	-9,269 Reduced 45.98%	10,889 $774,000
Q2 2022 Aug 16, 2022	BUY	$72.62 - $79.98 $942,171 - $1.04 Million	12,974 Added 180.6%	20,158 $1.55 Million
Q1 2022 Jun 08, 2022	BUY	$61.48 - $73.72 $209,954 - $251,753	3,415 Added 90.61%	7,184 $525,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $16,625 - $19,381	-310 Reduced 7.6%	3,769 $235,000
Q3 2021 Nov 08, 2021	BUY	$59.17 - $69.31 $4,378 - $5,128	74 Added 1.85%	4,079 $241,000
Q2 2021 Jul 27, 2021	BUY	$61.91 - $67.42 $247,949 - $270,017	4,005 New	4,005 $268,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Peachtree Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Peachtree Investment Partners, LLC with notifications on news.